Literature DB >> 12894346

Distinct genetic and epigenetic changes in medullary breast cancer.

P Osin1, Y-J Lu, J Stone, T Crook, R S Houlston, M Gasco, B A Gusterson, J Shipley.   

Abstract

Genetic instability resulting in chromosome aneuploidy or mismatch repair deficiency characterizes cancer. Medullary carcinoma (MC) of the breast is a specific form of breast cancer with unique clinical, epidemiologic, and prognostic features, suggesting distinctive tumorigenic pathways. To investigate the nature of the genetic changes associated with MC we analyzed a series of 22 tumors. Chromosomal imbalances were assessed by comparative genomic hybridization (CGH) and mismatch repair (MMR) deficiency tested for through assessment of microsatellite instability (MSI) and expression of MLH1 and MSH2 genes. MMR deficiency was detected in only a small proportion of cases. The chromosomal copy number changes showed some similarities to BRCA1-associated tumors. A high level of BRCA1 promoter hypermethylation was detected, suggesting a possible role of this gene in MC development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894346     DOI: 10.1177/106689690301100301

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  3 in total

1.  Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.

Authors:  Anne Vincent-Salomon; Nadège Gruel; Carlo Lucchesi; Gaëtan MacGrogan; Remi Dendale; Brigitte Sigal-Zafrani; Michel Longy; Virginie Raynal; Gaëlle Pierron; Isabelle de Mascarel; Corinne Taris; Dominique Stoppa-Lyonnet; Jean-Yves Pierga; Rémy Salmon; Xavier Sastre-Garau; Alain Fourquet; Olivier Delattre; Patricia de Cremoux; Alain Aurias
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

2.  Biomarkers of the metabolic syndrome and breast cancer prognosis.

Authors:  Qiu-Li Zhu; Wang-Hong Xu; Meng-Hua Tao
Journal:  Cancers (Basel)       Date:  2010-04-28       Impact factor: 6.639

3.  Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer.

Authors:  Bei Li; Rongxin Geng; Qi Wu; Qian Yang; Si Sun; Shan Zhu; Zhiliang Xu; Shengrong Sun
Journal:  Front Oncol       Date:  2020-03-12       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.